Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


OTC Allergy Drug Use Increases: A Symptom With Multiple Causes

Executive Summary

CHPA says growing use of allergy OTCs from 2009 through 2015 in the US is a sign of more consumers prioritizing self-care over using health care services, but allergy specialists say their patients often have to start with an OTC even when they have a prescription.


Related Content

Rhinocort Switch Makes Three In OTC Intranasal Corticosteroid Market
Flonase Allergy Relief Exclusivity Sliced Up By Label Carve-Out
Sanofi’s Nasacort First-In-Class Switch Receives FDA Approval
Nasacort AQ Switch Gets NDAC Nod Despite Pediatric Use Concerns
Zyrtec Launch Brings Big Boost To Johnson & Johnson, But Competition Grows
Steroid Nasal Sprays Not Suitable For Rx-to-OTC Switch – Task Force


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts